Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Pharmacol Exp Ther
2010 Mar 01;3323:1040-53. doi: 10.1124/jpet.109.161885.
Show Gene links
Show Anatomy links
Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxia.
Gee KW
,
Tran MB
,
Hogenkamp DJ
,
Johnstone TB
,
Bagnera RE
,
Yoshimura RF
,
Huang JC
,
Belluzzi JD
,
Whittemore ER
.
???displayArticle.abstract???
GABA(A) receptor (R) positive allosteric modulators that selectively modulate GABA(A)Rs containing beta(2)- and/or beta(3)- over beta(1)-subunits have been reported across diverse chemotypes. Examples include loreclezole, mefenamic acid, tracazolate, and etifoxine. In general,"beta(2/3)-selective" GABA(A)R positive allosteric modulators are nonbenzodiazepines (nonBZs), do not show alpha-subunit isoform selectivity, yet have anxiolytic efficacy with reduced ataxic/sedative effects in animal models and humans. Here, we report on an enantiomeric pair of nonBZ GABA(A)R positive allosteric modulators that demonstrate differential beta-subunit isoform selectivity. We have tested this enantiomeric pair along with a series of other beta(2/3)-subunit selective, alpha-subunit isoform-selective, BZ and nonBZ GABA(A) positive allosteric modulators using electrophysiological, pharmacokinetic, and behavioral assays to test the hypothesis that ataxia may be correlated with the extent of modulation at beta(1)-subunit-containing GABA(A)Rs. Our findings provide an alternative strategy for designing anxioselective allosteric modulators of the GABA(A)R with BZ-like anxiolytic efficacy by reducing or eliminating activity at beta(1)-subunit-containing GABA(A)Rs.
Asanuma,
GABAergic and pallidal terminals in the thalamic reticular nucleus of squirrel monkeys.
1994, Pubmed
Asanuma,
GABAergic and pallidal terminals in the thalamic reticular nucleus of squirrel monkeys.
1994,
Pubmed
Bare,
Synthesis and structure-activity relationships of a series of anxioselective pyrazolopyridine ester and amide anxiolytic agents.
1989,
Pubmed
Basile,
Anxioselective anxiolytics: can less be more?
2004,
Pubmed
Bourin,
Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models.
1992,
Pubmed
Crabbe,
Genetic determinants of sensitivity to diazepam in inbred mice.
1998,
Pubmed
Cryer,
Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs.
1998,
Pubmed
Daly,
Non-xanthine heterocycles: activity as antagonists of A1- and A2-adenosine receptors.
1988,
Pubmed
Fisher,
Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs.
1995,
Pubmed
Groves,
The role of GABAbeta2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole.
2006,
Pubmed
Halliwell,
Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid.
1999,
Pubmed
,
Xenbase
Hamon,
The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the beta subunit.
2003,
Pubmed
,
Xenbase
Harrison,
Mechanisms of sleep induction by GABA(A) receptor agonists.
2007,
Pubmed
Hartings,
High responsiveness and direction sensitivity of neurons in the rat thalamic reticular nucleus to vibrissa deflections.
2000,
Pubmed
Hazrati,
Projection from the external pallidum to the reticular thalamic nucleus in the squirrel monkey.
1991,
Pubmed
Hill-Venning,
Subunit-dependent interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor.
1997,
Pubmed
,
Xenbase
Hogenkamp,
Enaminone amides as novel orally active GABAA receptor modulators.
2007,
Pubmed
Huntsman,
Fast IPSCs in rat thalamic reticular nucleus require the GABAA receptor beta1 subunit.
2006,
Pubmed
LITCHFIELD,
A simplified method of evaluating dose-effect experiments.
1949,
Pubmed
Lippa,
Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.
2005,
Pubmed
,
Xenbase
McCormick,
Sleep and arousal: thalamocortical mechanisms.
1997,
Pubmed
McKernan,
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
2000,
Pubmed
Ng,
Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.
2007,
Pubmed
,
Xenbase
Nguyen,
Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
2006,
Pubmed
Paré,
Substantia nigra pars reticulata projects to the reticular thalamic nucleus of the cat: a morphological and electrophysiological study.
1990,
Pubmed
Pirker,
GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain.
2000,
Pubmed
Popik,
The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
2006,
Pubmed
,
Xenbase
Rudolph,
Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.
1999,
Pubmed
Smith,
Compounds exhibiting selective efficacy for different beta subunits of human recombinant gamma-aminobutyric acid A receptors.
2004,
Pubmed
Sun,
Distribution of alpha1, alpha4, gamma2, and delta subunits of GABAA receptors in hippocampal granule cells.
2004,
Pubmed
Thompson,
Tracazolate reveals a novel type of allosteric interaction with recombinant gamma-aminobutyric acid(A) receptors.
2002,
Pubmed
,
Xenbase
Van Dort,
Adenosine A(1) and A(2A) receptors in mouse prefrontal cortex modulate acetylcholine release and behavioral arousal.
2009,
Pubmed
Van der Werf,
The intralaminar and midline nuclei of the thalamus. Anatomical and functional evidence for participation in processes of arousal and awareness.
2002,
Pubmed
Whiting,
GABA-A receptors: a viable target for novel anxiolytics?
2006,
Pubmed
de Haas,
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
2008,
Pubmed
de Haas,
The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.
2009,
Pubmed
